In individuals with MM, serum transgelin, U IGFBP-7/creatinine and U TIMP2/creatinine ratios may have utility as biomarkers of predicting advanced chronic kidney disease stages. The gene discussed is IGFBP7; the disease is Miyoshi myopathy.